Hillsdale Investment Management Inc. Has $740,000 Holdings in MetLife, Inc. $MET

Hillsdale Investment Management Inc. grew its holdings in shares of MetLife, Inc. (NYSE:MET) by 4,500.0% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 9,200 shares of the financial services provider’s stock after purchasing an additional 9,000 shares during the period. Hillsdale Investment Management Inc.’s holdings in MetLife were worth $740,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. Brighton Jones LLC increased its position in shares of MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock worth $347,000 after purchasing an additional 351 shares during the last quarter. Avantax Advisory Services Inc. grew its stake in shares of MetLife by 6.1% in the first quarter. Avantax Advisory Services Inc. now owns 42,904 shares of the financial services provider’s stock valued at $3,445,000 after buying an additional 2,449 shares in the last quarter. Cetera Investment Advisers increased its holdings in MetLife by 16.5% during the first quarter. Cetera Investment Advisers now owns 220,540 shares of the financial services provider’s stock worth $17,707,000 after buying an additional 31,207 shares during the last quarter. Skandinaviska Enskilda Banken AB publ raised its position in MetLife by 5.5% during the first quarter. Skandinaviska Enskilda Banken AB publ now owns 130,058 shares of the financial services provider’s stock worth $10,442,000 after acquiring an additional 6,771 shares in the last quarter. Finally, HB Wealth Management LLC lifted its stake in MetLife by 47.7% in the first quarter. HB Wealth Management LLC now owns 30,162 shares of the financial services provider’s stock valued at $2,422,000 after acquiring an additional 9,742 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

MetLife stock opened at $75.00 on Monday. The company has a market capitalization of $49.42 billion, a price-to-earnings ratio of 12.71, a PEG ratio of 0.70 and a beta of 0.87. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The stock’s 50 day moving average is $79.33 and its 200-day moving average is $78.90.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.07. The business had revenue of $17.90 billion during the quarter, compared to the consensus estimate of $18.64 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm’s quarterly revenue was down 5.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.95 EPS. Equities research analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s dividend payout ratio (DPR) is currently 42.75%.

Analysts Set New Price Targets

MET has been the topic of a number of research analyst reports. Wolfe Research raised shares of MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. Barclays upped their price objective on MetLife from $93.00 to $98.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Jefferies Financial Group lifted their target price on MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Wells Fargo & Company dropped their price target on MetLife from $96.00 to $92.00 and set an “overweight” rating on the stock in a research note on Friday, November 7th. Finally, Cowen reaffirmed a “buy” rating on shares of MetLife in a report on Friday, August 22nd. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $95.00.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.